Literature DB >> 15321845

Factors associated with treatment initiation after osteoporosis screening.

Renee M Brennan1, Jean Wactawski-Wende, Carlos J Crespo, Jacek Dmochowski.   

Abstract

The prevalence of osteoporosis and factors associated with treatment initiation after detection of osteoporosis were determined for previously unscreened, postmenopausal women. Dual-energy x-ray absorptiometry screening was conducted in 1997-2000 as part of an ancillary study of the Buffalo, New York, center of the Women's Health Initiative Observational Study. A total of 945 women were previously unaware of their bone density, although, for 344 (36.4%), osteoporosis was newly detected through screening (T-score </= -2.5). Of those women, 250 (72.7%) discussed the results with a health care provider, and 140 (56.0%) initiated treatment after doing so. In multivariate logistic regression analyses, factors associated with treatment initiation were T-score (odds ratio (OR) = 0.39 per unit increase, 95% confidence interval (CI): 0.23, 0.67), routine medical care more often than yearly (OR = 2.08, 95% CI: 1.12, 3.86), college education (OR = 2.58, 95% CI: 1.25, 5.31), family income of >/=$50,000 (OR = 2.06, 95% CI: 1.03, 4.14), and discussing screening results with a gynecologist (OR = 3.20, 95% CI: 1.33, 7.67). These findings suggest that many postmenopausal women are unaware of their bone density and could benefit from screening. In this study, approximately half of the women with osteoporosis initiated treatment after screening. Disease severity, medical care frequency, education, income, and physician type predicted treatment initiation.

Entities:  

Mesh:

Year:  2004        PMID: 15321845     DOI: 10.1093/aje/kwh245

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  17 in total

1.  The effect of socioeconomic status on bone density testing in a public health-care system.

Authors:  S Demeter; W D Leslie; L Lix; L MacWilliam; G S Finlayson; M Reed
Journal:  Osteoporos Int       Date:  2006-09-20       Impact factor: 4.507

2.  Racial disparity in treatment of osteoporosis after diagnosis.

Authors:  I Hamrick; L M Whetstone; D M Cummings
Journal:  Osteoporos Int       Date:  2006-07-27       Impact factor: 4.507

3.  Correlates of use of antifracture therapy in older women with low bone mineral density.

Authors:  Kathryn M Ryder; Ronald I Shorr; Frances A Tylavsky; Andrew J Bush; Douglas C Bauer; Eleanor M Simonsick; Elsa S Strotmeyer; Tamara B Harris
Journal:  J Gen Intern Med       Date:  2006-06       Impact factor: 5.128

4.  Educational level and use of osteoporosis drugs in elderly men and women: a Swedish nationwide register-based study.

Authors:  J W Wastesson; G Ringbäck Weitoft; M G Parker; K Johnell
Journal:  Osteoporos Int       Date:  2012-02-21       Impact factor: 4.507

5.  The role of socioeconomic status on hip fracture.

Authors:  D S Zingmond; N F Soohoo; S L Silverman
Journal:  Osteoporos Int       Date:  2006-06-15       Impact factor: 4.507

Review 6.  Treatment of osteoporosis: current state of the art.

Authors:  Irene Hamrick; Sarina Schrager; Ann Marie Nye
Journal:  Wien Med Wochenschr       Date:  2014-12-12

7.  Osteoporosis treatment disparities: a 6-year aggregate analysis from national survey data.

Authors:  T D Cunningham; B S Di Pace; J Ullal
Journal:  Osteoporos Int       Date:  2014-06-05       Impact factor: 4.507

8.  Influence of education, marital status, occupation, and the place of living on skeletal status, fracture prevalence, and the course and effectiveness of osteoporotic therapy in women in the RAC-OST-POL Study.

Authors:  Wojciech Pluskiewicz; Piotr Adamczyk; Aleksandra Czekajło; Władysław Grzeszczak; Bogna Drozdzowska
Journal:  J Bone Miner Metab       Date:  2013-05-21       Impact factor: 2.626

9.  A cross-sectional study to estimate associations between education level and osteoporosis in a Chinese postmenopausal women sample.

Authors:  Hui-Hong Piao; Jiajia He; Keqin Zhang; Zihui Tang
Journal:  Int J Clin Exp Med       Date:  2015-11-15

10.  Predictors of oral bisphosphonate prescriptions in post-menopausal women with osteoporosis in a real-world setting in the USA.

Authors:  C Asche; R Nelson; C McAdam-Marx; M Jhaveri; X Ye
Journal:  Osteoporos Int       Date:  2009-10-02       Impact factor: 4.507

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.